Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof

  • US 10,759,779 B2
  • Filed: 01/30/2020
  • Issued: 09/01/2020
  • Est. Priority Date: 08/01/2017
  • Status: Active Grant
First Claim
Patent Images

1. A crystalline form CS2 of E-2006, wherein the X-ray powder diffraction pattern shows characteristic peaks at 2theta values of 7.8°

  • ±

    0.2°

    , 15.6°

    ±

    0.2° and

    11.4°

    ±

    0.2°

    using CuKα

    radiation.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×